ID: ALA4165141

Max Phase: Preclinical

Molecular Formula: C50H60N8O5

Molecular Weight: 853.08

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCn1cc(C[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC)C(=O)N[C@@H](CC(C)C)C(N)=O)c2ccccc21

Standard InChI:  InChI=1S/C50H60N8O5/c1-5-24-58-31-36(38-21-13-15-23-45(38)58)29-44(49(62)54-40(46(51)59)25-32(2)3)57-48(61)42(27-34-18-10-7-11-19-34)55-50(63)43(28-35-30-53-39-22-14-12-20-37(35)39)56-47(60)41(52-4)26-33-16-8-6-9-17-33/h6-23,30-32,40-44,52-53H,5,24-29H2,1-4H3,(H2,51,59)(H,54,62)(H,55,63)(H,56,60)(H,57,61)/t40-,41+,42-,43+,44+/m0/s1

Standard InChI Key:  CWSOMQHLNAVNQT-HSDWMVMWSA-N

Associated Targets(Human)

NCI-H69 709 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DMS-79 150 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 853.08Molecular Weight (Monoisotopic): 852.4687AlogP: 4.86#Rotatable Bonds: 22
Polar Surface Area: 192.24Molecular Species: NEUTRALHBA: 7HBD: 7
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.95CX Basic pKa: 8.34CX LogP: 6.08CX LogD: 5.09
Aromatic Rings: 6Heavy Atoms: 63QED Weighted: 0.05Np Likeness Score: -0.18

References

1. Haitham Abusara O, Freeman S, Aojula HS..  (2017)  Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain.,  137  [PMID:28595067] [10.1016/j.ejmech.2017.05.053]

Source